Filter
303
Filtered Results: 303
Text search:
Lymphatic
filariasis
Featured
Recommendations
35
New Publications
83
Language
Document type
No document type
127
Studies & Reports
74
Guidelines
41
Strategic & Response Plan
31
Manuals
14
Training Material
4
Videos
4
Infographics
2
Fact sheets
2
Brochures
1
Dashboards/Maps
1
Resource Platforms
1
Online Courses
1
Countries / Regions
Global
42
India
13
Ethiopia
10
Sierra Leone
9
Africa
9
Nepal
8
Liberia
8
Kenya
7
Uganda
7
Ghana
6
Malawi
6
Latin America and the Carribbean
6
Bangladesh
5
Zambia
5
South Sudan
5
Mozambique
4
Tanzania
4
South–East Asia Region
4
Indonesia
4
Burkina Faso
3
Saudi Arabia
3
Sudan
3
Yemen
3
Myanmar / Burma
3
Rwanda
2
Cameroon
2
Syria
2
Iran
2
Nigeria
2
Philippines
2
Asia
2
Jordan
2
Congo, Democratic Republic of
2
Lebanon
2
Djibouti
2
Egypt
2
Botswana
2
Iraq
2
Somalia
2
Pakistan
2
Timor Leste/ East Timor
1
Lesotho
1
Albania
1
Laos
1
Afghanistan
1
Zimbabwe
1
Morocco
1
Qatar
1
Haiti
1
Cambodia
1
West and Central Africa
1
Middle East and North Africa
1
Western Pacific Region
1
Western and Central Europe
1
Tunisia
1
East and Southern Africa
1
Brazil
1
Greece
1
Palestine
1
Georgia
1
Angola
1
Libya
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
122
Clinical Guidelines
38
Public Health
30
Key Resources
12
Capacity Building
3
Pharmacy & Technologies
3
Women & Child Health
2
Toolboxes
NTDs
113
Rapid Response
11
Planetary Health
9
NCDs
5
Caregiver
4
Pharmacy
4
Global Health Education
4
Mental Health
2
HIV
2
Cholera
2
Ebola & Marburg
2
COVID-19
2
Malaria
2
TB
1
Disability
1
Social Ethics
1
Health Financing Toolbox
1
Conflict
1
Zika
1
Polio
1
AMR
1
In 1997, the Fiftieth World Health Assembly adopted resolution WHA50.29 on the elimination of
lymphatic filariasis as a public health problem. Preliminary guidance from WHO printed in 2011 referred to “verification” as the official process by which the achievements of the Global Programme to El...
To eliminate lymphatic filariasis (LF) by 2020, the World Health Organization (WHO) has launched a campaign against the disease. Since the launch in 2000, significant progress has been made to achieve this ambitious goal. In this article we review the progress and status of the LF programme in Afric...
The purpose of this TPP is to communicate the minimum and ideal characteristics desired to meet the need for discriminating low levels of risk for transmission, i.e. targeted prevalence thresholds in the surveyed areas. An in vitro diagnostic test is needed for the detection of analyte(s) specific t...
During the 17 years since Surgical approaches to the urogenital manifestations of lymphatic filariasis was first published, there has been heightened awareness of the physical, economic and emotional burden of the genitourinary manifestations of filariasis. With the impetus to provide better guidanc...
The Western Pacific Region is the largest and most diverse region in the world, made up of 37 countries and territories in the Pacific, Oceania and parts of Asia, with a population of more than 1.9 billion people stretching over an area from China and Mongolia in the north to New Zealand in the sout...
The Global Programme to Eliminate Lymphatic Filariasis (LF) is using mass drug administration (MDA) of antifilarial medications to treat filarial infections, prevent disease and interrupt transmission. Almost 500 million people receive these medications each year. Clinical trials have recently shown...
This manual provides a framework for morbidity management and disability prevention of patients affected by NIDs and gives specific guidance for the proper care of patients suffering from chronic conditions caused by lymphatic filariasis, leprosy, trachoma, and Chagas disease. It is intended to be u...
The South-East Asia regional programme to eliminate lymphatic filariasis (LF) was launched in 2000. This study presents the progress and impact of the programme in the region.
Since the launch of the Global Programme to Eliminate Lymphatic Filariasis (GPELF) in 2000, more than 910 million people have received preventive chemotherapy for lymphatic filariasis (LF) and many thousands have received care for chronic manifestations of the disease. To achieve this, millions of c...
The Onchocerciasis Control Programme in West Africa (OCP) undertook regional and large scale frght against onchocerciasis in West Africa in 1974 using a vector control strategy. By 2002 OCP had succeeded in eliminating the disease as a public health, socio-economic and development problem in 10 out ...
Effective monitoring, epidemiological assessment and evaluation are necessary to achieve the aim of interrupting LF transmission. This manual is designed to ensure that national elimination programmes have available the best information on methodologies and procedures for monitoring MDA, appropriate...
Indoor residual spraying (IRS) involves applying residual insecticide to potential vector resting sites on the interior surfaces of human dwellings or other buildings. The main aim of IRS is to kill vectors before they are able to transmit pathogens to humans. When carried out correctly, IRS has his...
The Alere Filariaisis Test Strip (FTS) is a diagnostic test used to detect filarial antigens for lymphatic filariasis. This training video was developed by ENVISION in collaboration with the US Centers for Disease Control and Prevention, with funding provided by the US Agency for International Deve...
Better drug regimens for mass drug administration (MDA) could accelerate the Global Programme to Eliminate Lymphatic Filariasis (LF). This community study was designed to compare the safety and efficacy of MDA with IDA (ivermectin, diethylcarbamazine and albendazole) or DA (diethylcarbamazine and ...
PLoS Negl Trop Dis 16(10): e0009774. Although the practice of communication is often called upon when intervening asn involgvingcommunties affected by NTD's, the disciplinary framewokr of healt communication research has been largely absent from NTD strategies. To illustrate how practices conceptual...
Many countries have made significant progress in the implementation of World Health Organization recommended preventive chemotherapy strategy, to eliminate lymphatic filariasis (LF). However, pertinent challenges such as the existence of areas of residual infections in disease endemic districts pose...
Tis first edition describes the standard operating procedures for health products for NTDs amenable to preventive chemotherapy and the medicines donated to treat them. These include albendazole for lymphatic filariasis and soil-transmitted helminthiases; azithromycin for trachoma and yaws; diethylca...
